MedTrace Logo

Safety and Efficacy Study of a Food Supplement for Pregnant and Lactating Women

NCT02190565 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2018-12-05

No results posted yet for this study

Summary

The purpose of this study is to determine whether a food supplement consisting of vitamins, minerals and fish oil taken during and after pregnancy can decrease the need for additional iron supplementation due to anemia during pregnancy, and optimize levels of nutritional markers such as vitamin D and docosahexaenoic acid (DHA, an omega 3 fatty acid) in maternal blood and breast milk, compared to placebo.

Conditions

  • Anaemia

Interventions

DIETARY_SUPPLEMENT

Food supplement

Randomized double-blind, placebo-controlled

Sponsors & Collaborators

Principal Investigators

  • Angelica Lindén Hirschberg, Professor · Karolinska Institutet

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-07
Primary Completion
2018-04-07
Completion
2018-04-07

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02190565 on ClinicalTrials.gov